Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

349
Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
349

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

GLP-1-Based Therapies in Type 1 Diabetes: Emerging Evidence on Cardiovascular, Renal, and Safety Outcomes.

Diabetes, obesity & metabolism·2026
Same author

Proteostasis is disrupted in human endothelial cells by serum from ATTR patients and is rescued by tafamidis treatment.

Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis·2026
Same author

Optimal Antithrombotic Therapy for Peripheral Artery Disease: A Systematic Review and Network Meta-Analysis.

Journal of the American Heart Association·2026
Same author

Finerenone Across Cardiovascular-Kidney-Metabolic Syndrome Stages: Post Hoc Analysis of the FIDELITY Randomized Clinical Trials.

JAMA cardiology·2026
Same author

Sotatercept as an Add-On to Background Therapy in Idiopathic Pulmonary Arterial Hypertension: Insights from a Real-World Cohort.

Pharmaceuticals (Basel, Switzerland)·2026
Same author

Antiplatelet therapy for patients with stable coronary artery disease receiving oral anticoagulation: A meta-analysis of randomized controlled trials.

Journal of cardiology·2026

Related Experiment Video

Updated: Jan 5, 2026

Upper-extremity Approach for Secondary Access in Transfemoral Transcatheter Aortic Valve Implantation
06:04

Upper-extremity Approach for Secondary Access in Transfemoral Transcatheter Aortic Valve Implantation

Published on: August 8, 2025

471

Advances in transcatheter aortic valve replacement.

Tomo Ando1, Alexandros Briasoulis2, Sidakpal Panaich2

  • 1Wayne State University/Detroit Medical Center, Detroit, Michigan, United States.

Journal of Geriatric Cardiology : JGC
|October 25, 2019
PubMed
Summary

Transcatheter aortic valve replacement (TAVR) evidence is growing, impacting clinical decisions. This review covers TAVR advances in patient selection, indications, complications, and new technologies.

Keywords:
Aortic stenosisPeriprocedural complicationsSurgical riskTranscatheter aortic valve replacement

More Related Videos

Transcatheter Pulmonary Valve Replacement from Autologous Pericardium with a Self-Expandable Nitinol Stent in an Adult Sheep Model
05:31

Transcatheter Pulmonary Valve Replacement from Autologous Pericardium with a Self-Expandable Nitinol Stent in an Adult Sheep Model

Published on: June 8, 2022

3.3K
Technique and Patient Selection Criteria of Right Anterior Mini-Thoracotomy for Minimal Access Aortic Valve Replacement
08:50

Technique and Patient Selection Criteria of Right Anterior Mini-Thoracotomy for Minimal Access Aortic Valve Replacement

Published on: March 26, 2018

12.1K

Related Experiment Videos

Last Updated: Jan 5, 2026

Upper-extremity Approach for Secondary Access in Transfemoral Transcatheter Aortic Valve Implantation
06:04

Upper-extremity Approach for Secondary Access in Transfemoral Transcatheter Aortic Valve Implantation

Published on: August 8, 2025

471
Transcatheter Pulmonary Valve Replacement from Autologous Pericardium with a Self-Expandable Nitinol Stent in an Adult Sheep Model
05:31

Transcatheter Pulmonary Valve Replacement from Autologous Pericardium with a Self-Expandable Nitinol Stent in an Adult Sheep Model

Published on: June 8, 2022

3.3K
Technique and Patient Selection Criteria of Right Anterior Mini-Thoracotomy for Minimal Access Aortic Valve Replacement
08:50

Technique and Patient Selection Criteria of Right Anterior Mini-Thoracotomy for Minimal Access Aortic Valve Replacement

Published on: March 26, 2018

12.1K

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Medical Technology

Background:

  • Transcatheter aortic valve replacement (TAVR) has seen rapid evidence accumulation.
  • Its clinical decision-making relevance is increasing.
  • The field is evolving quickly.

Purpose of the Study:

  • To review recent advances in transcatheter aortic valve replacement (TAVR).
  • To discuss key areas including patient selection, expanded indications, complication management, and novel technologies.

Main Methods:

  • Literature review of recent studies and clinical trials in TAVR.
  • Synthesis of evidence on patient selection criteria.
  • Analysis of data on expanding TAVR indications.
  • Review of reported complications and their management.
  • Overview of emerging TAVR technologies and future directions.

Main Results:

  • Significant advancements in TAVR patient selection criteria.
  • Broadening of TAVR indications to lower-risk patient groups.
  • Improved understanding and management of TAVR-related complications.
  • Introduction of next-generation TAVR devices and techniques.

Conclusions:

  • TAVR is a rapidly evolving field with significant recent advancements.
  • Evidence supports TAVR's expanding role in managing aortic stenosis.
  • Ongoing research and technological innovation continue to shape TAVR practice.